Featured Events!


2019 Pre-Filled Syringes Forum, San Diego, CA

September 4-5, 2019, Sheraton La Jolla, La Jolla, CA

With the Pre-Filled Syringes market expected to top $16 billion dollars by 2021, the industry is looking for next generation materials, technologies and production strategies to streamline commercialization and to adapt quickly to a changing regulatory environment. Pharma Ed Resources, an industry leader since 2004 in delivering market-driven research on PFS, is proud to announce its 2019 Pre-Filled Syringes Forum. Pharma Ed brings together top scientists, regulatory experts and innovators to share best practices and the latest research in this field, enabling you to maximize your organization's leverage in this dynamic and growing market.

Featuring In-Depth Coverage On:

  • Integrated Strategy and Approach to Combination Product Development for Biologics
  • Challenges and Opportunities for Development of Stability Program for Combination Products
  • Tools for Calculating the Return on Investment in Human Factors Engineering for Injection Systems
  • Post-marketing Safety Reporting for Combination Products
  • Analytical Challenges and State-of-the-Art Solutions Related to Chemical Safety Assessment of Pre-Filled Syringes
  • Combi Filling - Challenges and Solutions
  • Platform-Based Drug Delivery Combination Product Risk Management: Challenges and Best Practices
  • Precision Capability of Peristaltic Pump for Filling High-Concentration Monoclonal Antibody Solutions at Low Fill Volumes
  • Biologics Formulation for COP Syringe Optimized to Eliminating Use of Surfactant
  • Container Closure Integrity Assessment of PFS and Cartridges in Manufacturing and Transportation – Options, Approaches and Future Trends in Ensuring Product Safety
  • Particles in Intravitreal Injections
  • Flexible Primary Container Closure Systems: Reimagining the Future of Parenteral Drug Delivery
  • Pre-Filled Syringes Novel Approach & Technology: Increasing Safety and Performances in the Delivery of Demanding Biodrugs
  • Framework For Evaluation of Pre-Filled Syringe Systems
  • The Role of Human Factors in Evaluating Innovative Injectables
  • Tackle Pre-Filled Syringe QC With Bouncer
  • What Is "New" In the Area of Autoinjectors, Pen Injectors, Patch Pumps and Wearables?
  • The Evolution in Vacuum Decay Leak Testing Technology

With Representation From:

  • IMA Life
  • FDA
  • Takeda
  • Biogen
  • Johnson & Johnson
  • Eli-Lilly & Co.
  • Medimmune
  • Genentech
  • Bosch
  • Intertek
  • Ompi of America
  • Ypsomed
  • Zeon
  • Toxikon
  • Gessnet
  • West
  • Merck
  • Suttons Creek

Silver Sponsor:

Event Sponsors:

Media Partners:

Standard Registration: $1895


Microneedle, Transdermal & Intradermal Drug Delivery Systems, 2019

September 18-19, 2019, Metro Meeting Centers, Boston, MA

For the past six years, Pharma Ed's annual Transdermal & Intradermal Drug Delivery conference has attracted hundreds of attendees from the US and abroad. We bring together top experts from academia and industry to share their research in this emerging field of drug and biologics delivery.

Featuring In-Depth Coverage On:

  • Next Generation MN Systems: Delivering High Drug Doses Transdermally Using Microarray Patches
  • In Vitro Permeation Testing in Dermal Drug Discovery and Development
  • Overcoming Unique Challenges Facing Skin Delivery Systems
  • Delivering Therapeutic Peptides—A Case Study Using a Solid Microstructured TD System
  • Latest Advances in Microneedle Drug and Vaccine Delivery
  • Optimizing Dissolving Microneedles & Coated Microneedles for Drug Delivery
  • Improving Formulation Design in Dermal/Transdermal Drug Delivery
  • Mechanisms of Dermal and Transdermal Absorption of Drugs
  • Regulatory and Experimental Considerations for Extractable and Leachable Analysis of TDD Systems
  • Exploring the Therapeutic Potential of Cannabinoid Medicines Via Skin Delivery
  • And more!

With Representation From:

  • 3M
  • University of Maryland
  • Merck
  • Queens College
  • UC Dublin
  • Diteba
  • JUVIC
  • Vaxxess
  • Zosano Pharma
  • Mercer University
  • Texas Tech
  • Gattefosse
  • Incyte Corporation
  • University of Miss.
  • Intertek
  • Material Needs Consulting
  • PATH

Event Sponsors:

Media Sponsor:


Data Integrity & Pharmaceutical Quality Compliance Summit

October 3rd and 4th, 2019, Sheraton La Jolla, CA

Featuring In-Depth Coverage On:

  • Regulatory Guidance for Data Integrity
  • A Regulatory Global View on Data Integrity and its Importance
  • Examining FDA Integrity Guideline
  • Creating Data Integrity Programs
  • Data Integrity During Process Validation and Commerical Product Transfers
  • CMOs and Data Integrity
  • How to Detect the Lack of Data Integrity
  • Data Integrity for Complex Analytical Systems. How to Deal Effectively with Vendor-Provided COTS Solutions?
  • Data Integrity in cGMP realized in global Pharma corporate projects
  • Performing a Risk Assessment for Data Deficiencies
  • Data Lifecycle Management
  • Process Validation and Technology Transfer of Biologics and Vaccines
  • Software Validation Case Study: Validation of MES System

With Representation From:

Event Sponsors:


Cleaning Validation 2019

Cleaning Standards and Best Practices for Drugs, Biologics, and Medical Devices

October 9-10, San Diego, CA

Can you implement the best science-based, risk-based, and statistics-based approaches for cleaning validation? Today's regulators are now expecting ADE monographs and risk assessments of your organization's cleaning validation programs. This two-day intensive summit brings together industry leaders to illuminate best practices in cleaning validation.

With Comprehensive Coverage On:

  • Understanding the 2018 FDA Guidance on Regulatory Submissions for Cleaning Validation
  • Current Best Practices for Regulatory Audits of Cleaning and Cleaning Validation Practices
  • ASTM Standards in Medical Device Cleaning Validation
  • Science and Risk Based Cleaning FMEA and Cleaning Control Strategy
  • Process & Cleaning Validation during Technology Transfer of Biologics & Vaccines
  • Creating a Robust Cleaning Protocol and Report
  • Statistics in Validation - For Non-Statisticians
  • Writing Cleaning Validation Master Plans and Ongoing Cleaning Maintenance
  • Analytical Approach for Implementation of Visual Inspection
  • Establishing Cleaning Validation Limits for Residue
  • Strategies for Lean Cleaning Validation Maintenance for Biologics
  • Common Issues with Cleaning and Maintaining Stainless Steel Equipment
  • Influence of Material Chemistry and Process History on Medical Device Cleaning Analysis and Chemical Risk Assessment
  • Optimizing Manual Cleaning Validation Processes and Operator Qualification for Manual Cleaning
  • And more!

With Representation From:

  • FDA
  • Bristol-Myers Squibb
  • Astra Zeneca
  • GSK
  • Novo Nordisk
  • Thermo Fisher
  • Alcon
  • STERIS
  • Novatek International
  • Life Scientia
  • Eurofins Medical Device Testing
  • Dober
  • Cambridge Polymer Group
  • Hyde Consulting
  • Design Quality Consultants
  • Koshy & Associates

Event Sponsors:

Media Partner:

Early Bird Special: Register by August 1st and Receive a $300 Discount off of Standard Pricing!!


Extractables & Leachables Forum 2019- West Coast

November 18-19, 2019 Sheraton La Jolla, CA

Ensuring Quality, Safety, Suitability and Regulatory Compliance for Drugs, Biologics and Medical Devices

This two-day conference will examine the safety, quality, and regulatory issues involved in a wide array of contexts central to the pharmaceutical and biotech industries, including drug packaging and delivery components, single-use systems, medical devices, and parenteral drug products. In addition, we will focus closely on the keys to satisfying recent revisions to several applicable USP chapters and the recently revised standards contained in ISO 10993.

Featuring In-Depth Coverage On:

  • The Ongoing Development of USP Chapters and Dealing with Materials and Components Used in Pharmaceutical Manufacturing Systems
  • Issues Frequently Observed in Analytical Evaluation of Leachables in Drug Products (An FDA Review Experience)
  • Toxicological Risk assessment of Medical Device Constituents-The New Working Draft of ISO 10993-17
  • Understanding the Major Revisions to ISO 10993 and the New European Medical Device Regulations
  • ISO 10993-18: Chemical Characterization of Medical Devices
  • Application of ISO 109993-12 Exhaustive Extraction to Support Biocompatibility of Implantable Devices
  • Exploring Biocompatibility Vs. Chemical Assessment in E&L Study Design
  • Revisiting the PQRI/USP Identification Categories for Leachables and Extractables
  • The Use of Simulation Extractions to Address Leachables for Single Use SystemsExtractable and Leachable Evaluation for Complex Pharmaceutical Formulations
  • The Proper Use of Extractables Data - Aspects Beyond Extractables Measurement
  • Advanced Identification Methods for E/L from Packaging & Manufacturing Components
  • Understanding Leaching Associated with Lyophilized Drug Products Stored in Vial/Stopper Packaging Systems

With Representation From:

  • FDA
  • PPD
  • Sartorius Stedim
  • VR Analytical
  • Intertek
  • Med Institute
  • Triad Scientific Solutions
  • Nitto Avecia
  • Knoell Germany GmbH
  • Material Needs Consulting
  • Eakins & Associates
  • Risk Science Consortium
  • SGS
  • Pall
  • Agilent
  • Toxikon
  • WuXi App Tec

Event Sponsors:


Canna-Pharma 2019

Advancing the Science of Medical Cannabis Through GMP, Quality Control, Analytical Testing & Regulatory Compliance

November 13-14, 2019 Sheraton La Jolla, CA

The retail cannabis market in North America will soon exceed $25 billion. Though the federal government still classifies cannabis as illegal, 33 states have approved its use for medicinal purposes, and 10 states have made recreational use legal as well. In 2018 Canada became the first nation in the western hemisphere to legalize marijuana for both recreational and medicinal use, making it the largest national market for legal cannabis worldwide. Nevertheless, the state of scientific knowledge on medicinal cannabis remains immature, and the regulatory environment in North America fragmented and contested. That is why you cannot afford to miss Pharma Ed's Canna-Pharma 2019. This two-day event will explicitly link current knowledge and practice in the pharmaceutical and cannabis industries, providing a forum for scientific dialogue aimed at both advancing and applying best practices in this growing field. Research scientists, analytical experts, drug developers, drug device manufactures, cleaning validation experts, cannabis cultivators and labs, and public policy makers will come together to advance the science of cannabis.

Featuring Expert Speakers From

  • ASTM Committee D37
  • NRC-Canada
  • AOAC Cannabis Working Group
  • AHPA
  • USP Medical Cannabis Expert Committee
  • International Cannabis & Cannabinoid Institute
  • Agilent Technologies
  • Gattefossè
  • Steep Hill Labs
  • Americans for Safe Access
  • Diteba
  • Steris
  • Alconox
  • Medicinal Genomics
  • University of Maryland
  • VividGro
  • LexKannabis LLC
  • GBS Global Biopharma
  • Vas Analytical
  • Colorado Department of Public Health & Environment
  • Maryland Medical Cannabis Commission
  • MCSB, CA Department of Public Health

And Comprehensive Coverage On:

  • Challenges in Creating Standards for Quality Control of Cannabis Derived Products
  • Updates from Industry Working Groups: ASTM D37, AHPA, USP, & AOAC International
  • Analytical Testing Strategies for Pesticides, Trace Metals & Other Contaminants
  • Regulatory Panel Discussion—Hear from the Experts
  • Cannabis Genetics: The Path to Better Medicinal Cannabis
  • Hot Topics in Therapeutic Cannabis Research
  • Key Formulation Considerations for Improved Bioavailability of Cannabinoids
  • Evaluating the Volatile Constituents of Different Cannabis Varieties using Various Sample Preparation Approaches, and Mass Spec Detection
  • New Approaches to Pesticide Analysis in Cannabis
  • Environmental Monitoring for GMP Compliance in Grow Facilities
  • Cannabis Microbiome Sequencing: Implications for Cannabis Safety Testing
  • Cleaning Validation and GMPs for Medicinal Cannabis Products
  • The Therapeutic Potential of Cannabinoid Medicines Applied on the Skin
  • Intellectual Property Considerations for Medical Cannabis
  • And Much More!

Event Sponsors:

Media Partners:

Register by August 15th for Early Bird Discount!


Why PharmaEd?

Profitable Networking

Industry innovators and established professionals meet to share ideas, forge relationships, and imagine new opportunities.

Experience You Trust

Our team has over four decades of combined experience producing conferences and delivering real value to the pharma industry.

An Industry Leader

Pharma Ed has collaborated with over 250 companies and organizations to produce some of the most informative meetings in the industry.

Our Mission

To deliver the most current, market-driven information to meet your research, product development, regulatory, quality assurance, and technical needs.

Relevant Training

Cutting-edge knowledge drawn from top pharmaceutical, biotech, and academic experts.

Sponsorship Opportunities!

Sponsor a PharmaEd event and set your business apart!

CLICK HERE TO LEARN MORE

What People Are Saying About
Pharma Ed Events

"A Fantastic meeting. I was interested in so many of the talks and I met several clients - current and potential."
- Principal Scientist, Aptuit SSCI

"I really enjoyed the meeting... Stronger speakers and more in depth coverage than some of the others on the market."
- Director, Emerson Resources, Inc.

"Thank you again for such an excellent program - it was very informative and enjoyable."
- Sr. Principal Scientist, Bausch + Lomb

"I go to a lot of conferences, and this was an excellent one."
- Sr. Scientist, Boehringer Ingelheim

"Great audience, with good choice of speakers. Would love to attend again."
- Principal Scientist, Pfizer

"I greatly enjoyed the conference. I found the topics relevant and containing great content. I look forward to bringing the knowledge and principles to my role in R&D."
- Manager, CSL Behring

"I was very pleased with the material presented, and the expertise of the presenters. I will be taking much valuable/applicable knowledge back to my company."
- QA Director, Biothera

"Each and every presentation contained information that I found to be useful and relevant and many presentations left me with ideas and concepts that I look forward to considering in greater detail."
- Distinguished Scientist, Baxter

"The presentations & experience of the presenters was very instructive & helpful toward building my programs."
- QA/Corporate Director, Medicago, Inc.

"This is a valuable conference, with many expert speakers."
- Product Manager, EMD Millipore

"I really enjoyed it. I feel engaged and like there is a lot to learn."
- Assoc. Scientist, Bristol-Myers Squibb

"Very good conference with knowledgeable presenters, good feedback, and 'real world' examples/takeaways."
- Assoc. Director of PV, Shire

"Great mix of topics and excellent networking sessions."
- Deputy Director, Sanofi Pasteur

"Very useful conference for us. Learned a lot from all the presentations."
- Scientist I, Amneal Pharmaceuticals

"I am new to the med device E/L scene, so I attended as a learning opportunity and to begin to get up to speed. I feel the conference was very informative and balanced various subject areas as well. I'll definitely plan on attending again."
- Research Toxicologist, NSF International

"The presentations were at a good level of detail."
- Project lead, Biogen

"What an excellent conference! I enjoyed it very much and I think I gained a wealth of information that I’m going to be able to apply in my organization. I’ll definitely recommend it to my colleagues."
- Director, Quality Assurance, Exelixis

"An excellent opportunity to learn and discover new devices."
- Director, Manufacturing and Development, Heron Therapeutics